Prevention of Lymphocyte Apoptosis—A Potential Treatment of Sepsis?
Open Access
- 15 November 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 41 (Supplement), S465-S469
- https://doi.org/10.1086/431998
Abstract
Sepsis is the leading cause of death in surgical intensive care units and is a major cause of morbidity and mortality in neonatal and medical intensiKeywords
This publication has 48 references indexed in Scilit:
- In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic miceBlood, 2005
- INCREASED LYMPHOID TISSUE APOPTOSIS IN BABOONS WITH BACTEREMIC SHOCKShock, 2004
- Differential Efficacy of Caspase Inhibitors on Apoptosis Markers during Sepsis in Rats and Implication for Fractional Inhibition Requirements for TherapeuticsThe Journal of Experimental Medicine, 2004
- Caspase-3 regulates cell cycle in B cells: a consequence of substrate specificityNature Immunology, 2003
- Caspase inhibition causes hyperacute tumor necrosis factor–induced shock via oxidative stress and phospholipase A2Nature Immunology, 2003
- The Pathophysiology and Treatment of SepsisNew England Journal of Medicine, 2003
- Early Circulating Lymphocyte Apoptosis in Human Septic Shock Is Associated with Poor OutcomeShock, 2002
- The caspase inhibitor z-VAD is more effective than CD18 adhesion blockade in reducing muscle ischemia-reperfusion injury: implication for clinical trialsBlood, 2002
- Synergistic protective effect of caspase inhibitors and bFGF against brain injury induced by transient focal ischaemiaBritish Journal of Pharmacology, 2001
- Proapoptotic BAX and BAK: A Requisite Gateway to Mitochondrial Dysfunction and DeathScience, 2001